Participated · Series C · Jun 2026

Stepful offers a vertically integrated, AI-enabled training platform that delivers school-as-a-service to health systems, covering instruction, simulation, assessment, and workforce planning. The platform provides employer-sponsored, debt-free pathways enabling learners to move from a high school diploma to healthcare careers while remaining in the workforce and avoiding traditional trade-school debt. Stepful connects graduates directly to job opportunities after certification and reports graduating more than 32,000 practice-ready healthcare workers. The company serves 35+ major healthcare system clients, including Mount Sinai, Ochsner, and Providence, and has seen meaningful revenue growth. Stepful plans to expand partnerships with hospitals and health systems and to launch advanced degree programs in nursing, respiratory therapy, and imaging while accelerating its AI capabilities. The company was founded by Carl Madi, Tressia Hobeika, and Edoardo Serra.

Participated · Seed · May 2026

Kubera Health provides an AI-native platform that converts a customer's payor-provider contracts, amendments, fee schedules, and policies into structured rules that run continuously against claims and payment data. Its product suite includes Contract Intelligence and a Contract Modeler for organizing documents, tracking deadlines, benchmarking terms, and modeling contractual changes against historical claims, plus Payment Auditing and Policy Intelligence to surface discrepancies and bring payor coverage rules into the same system. The company primarily targets mid-to-large health systems with complex managed care operations and says every customer to date has expanded their engagement, with Hollywood Presbyterian Medical Center cited as a user. Founder and CEO Roja Garimella launched the company from experience at Humana and Commonwealth Care Alliance. Following a $6.5 million seed round led by Upfront Ventures, Kubera plans to invest the proceeds in product, engineering, go-to-market, expanding into value-based care contract structures, and building a payment recovery layer.

Participated · Series B · May 2026

Founded in 2021 and headquartered in San Diego, 9amHealth provides AI-enabled virtual specialty care for conditions such as obesity, diabetes, hypertension, and dyslipidemia. The company offers an integrated model combining specialized clinicians (including endocrinologists and obesity medicine specialists), at-home lab testing, medication management, and continuous care. 9amHealth partners with employers, health plans, and pharmacy benefit managers and reports more than $50 million in projected medical and pharmacy savings across two Fortune 100 employers. It has delivered pharmacy cost savings amid rising demand for GLP-1 therapies while improving engagement and clinical outcomes. Backed by investors including Define Ventures, SemperVirens VC, 7Wire Ventures, and The Cigna Group Ventures, the company plans to expand its platform to manage a broader set of high-cost, specialty-level chronic conditions.

Participated · Series A · Feb 2026

Take2 is an AI agents platform focused on streamlining healthcare recruiting. Its flagship product, the AI Interviewer, autonomously conducts phone interviews around the clock, evaluates candidates, records calls, and syncs results directly into applicant tracking systems without human intervention. Trained on healthcare-specific hiring data, the system delivers predictive insights that improve quality of hire and employee retention while addressing high vacancy costs and turnover in the sector. The company already serves several of the largest U.S. health systems and reports growing adoption as organizations seek faster, more scalable staffing solutions. With new capital, Take2 intends to launch additional agents that handle sourcing, screening, credential verification, scheduling, and onboarding, moving toward fully automating the end-to-end hiring funnel. Management believes the platform can save healthcare providers millions of dollars each year by reducing manual workload and improving retention. The firm has just secured a $14 million Series A to accelerate these plans.

Participated · Series D · Feb 2026

Headquartered in Palo Alto, Midi Health operates a nationwide virtual clinic that addresses gaps in women’s healthcare from perimenopause and menopause to broader chronic and preventive needs. The company’s proprietary AI engine analyzes patient charts to personalize diagnosis, streamline scheduling and documentation, and continuously refine clinical protocols using one of the industry’s largest women’s-health datasets. Midi currently has insurance contracts that give more than 45 million U.S. women in-network access to its services, and over 25,000 patients seek care on the platform each week. Outcomes data show a 28-percentage-point increase in breast-cancer screening adherence, an 11-point rise in colorectal screening adherence, and up to a 13 percent reduction in total cost of care, alongside clinically significant reductions in A1c and LDL levels. The business complements its clinical model with an expanding specialist roster covering OB-GYN, cardiology, endocrinology, mood disorders, dermatology, longevity, and more. Recent executive hires from Tesla, Google, Meta, Lyft, and Omada Health signal a push to scale operations and brand awareness. Following its latest financing, Midi is valued at more than $1 billion and plans to broaden its AI capabilities and extend comprehensive women’s care across every life stage.